r.yildiz
Submits third-party assay reports on material purchased directly. Based in Antalya.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
7
n=7
Annotations
0
n=0
Median purity submitted
99.16%
n=7
Suppliers covered
5
n=7
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042799 | Selank | GGPeps | GGPE-2602-G2056 | Nordanalyt | 2026-Q3 | 98.77 | 8.33 | — | Supplier-supplied | 0 | FAIL |
| AX-2026-042280 | SLU-PP-332 | Homopeptide | HOMO-2602-Y2822 | VendorInvestigate | 2026-Q3 | 99.16 | 5.05 | 105.8 | Buyer-sourced | 0 | PASS |
| AX-2025-019656 | SS-31 (Elamipretide) | Homopeptide | HOMO-2507-B2039 | VendorInvestigate | 2025-Q4 | 98.23 | 5.74 | 90.0 | Buyer-sourced | 0 | FAIL |
| AX-2025-021160 | TB-500 | WXT | WXT-2502-A5571 | Janoshik | 2025-Q3 | 99.17 | 2.90 | 107.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020165 | Liraglutide | GGPeps | GGPE-2505-W9629 | Janoshik | 2025-Q4 | 98.18 | 7.21 | 104.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018866 | Desmopressin | QSC | QSC-2505-N8999 | PeptideMeter | 2025-Q3 | 99.93 | 4.57 | 95.1 | Supplier-supplied | 0 | PASS |
| AX-2024-004861 | Exenatide | SWB | SWB-2403-W5240 | Medutest | 2024-Q3 | 99.90 | 2.91 | — | Supplier-supplied | 0 | PASS |
| Supplier | Records | Median purity |
|---|---|---|
| GGPeps | 2 | n<3 |
| Homopeptide | 2 | n<3 |
| WXT | 1 | n<3 |
| QSC | 1 | n<3 |
| SWB | 1 | n<3 |